Pulnovo Raises Millions to Develop Its PAH Device and Trials

Pulnovo Raises Millions to Develop Its PAH Device and Trials

301727

Pulnovo Raises Millions to Develop Its PAH Device and Trials

Pulnovo Medical recently raised an undisclosed amount totaling millions of dollars in investment funding to support clinical trials and product development related to pulmonary arterial hypertension (PAH). “The road of global medical innovation has never been an easy journey,” Cynthia Chen, Pulnovo’s executive president, said in a press release. “Today we are honored for the recognition and support from OrbiMed, Cenova Capital, Lilly Asia Ventures (LAV), and GaoRong Capital,” Chen said. “We are confident and…

You must be logged in to read/download the full post.